Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1997 Apr;87(4):676–680. doi: 10.2105/ajph.87.4.676

Hysterectomy, oophorectomy, and heart disease risk factors in older women.

D Kritz-Silverstein 1, E Barrett-Connor 1, D L Wingard 1
PMCID: PMC1380855  PMID: 9146454

Abstract

OBJECTIVES: This study examined the relation of hysterectomy and oophorectomy to heart disease risk factors. METHODS: Data were collected and analyzed for 1150 women aged 50 through 89. RESULTS: Of these women, 21.8% reported hysterectomy with bilateral oophorectomy; 22.1%, hysterectomy with ovarian conservation. Compared with women without hysterectomy, oophorectomized women, especially those 20 or more years postmenopause, had increased lipids, lipoproteins, glucose, and insulin; blood pressures were increased among current estrogen users. Women with hysterectomies with ovarian conservation had similar or more favorable risk factors than nonhysterectomized women. CONCLUSIONS: Bilateral oophorectomy, but not hysterectomy, may have long-term negative consequences for heart disease risk factors not totally ameliorated by estrogen use.

Full text

PDF
680

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brett K. M., Madans J. H. Hysterectomy use: the correspondence between self-reports and hospital records. Am J Public Health. 1994 Oct;84(10):1653–1655. doi: 10.2105/ajph.84.10.1653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Castelo-Branco C., Casals E., Sanllehy C., González-Merlo J., Iglesias X. Effects of oophorectomy and hormone replacement therapy on plasma lipids. Maturitas. 1993 Sep;17(2):113–122. doi: 10.1016/0378-5122(93)90006-4. [DOI] [PubMed] [Google Scholar]
  3. Chilvers C. E., Pike M. C., Taylor C. N., Hermon C., Crossley B., Smith S. J. General practitioner notes as a source of information for case-control studies in young women. UK National Case-Control Study Group. J Epidemiol Community Health. 1994 Feb;48(1):92–97. doi: 10.1136/jech.48.1.92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Colditz G. A., Willett W. C., Stampfer M. J., Rosner B., Speizer F. E., Hennekens C. H. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987 Apr 30;316(18):1105–1110. doi: 10.1056/NEJM198704303161801. [DOI] [PubMed] [Google Scholar]
  5. Desbuquois B., Aurbach G. D. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab. 1971 Nov;33(5):732–738. doi: 10.1210/jcem-33-5-732. [DOI] [PubMed] [Google Scholar]
  6. Farish E., Fletcher C. D., Hart D. M., Smith M. L. Effects of bilateral oophorectomy on lipoprotein metabolism. Br J Obstet Gynaecol. 1990 Jan;97(1):78–82. doi: 10.1111/j.1471-0528.1990.tb01721.x. [DOI] [PubMed] [Google Scholar]
  7. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed] [Google Scholar]
  8. Gordon T., Kannel W. B., Hjortland M. C., McNamara P. M. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med. 1978 Aug;89(2):157–161. doi: 10.7326/0003-4819-89-2-157. [DOI] [PubMed] [Google Scholar]
  9. Grady D., Rubin S. M., Petitti D. B., Fox C. S., Black D., Ettinger B., Ernster V. L., Cummings S. R. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992 Dec 15;117(12):1016–1037. doi: 10.7326/0003-4819-117-12-1016. [DOI] [PubMed] [Google Scholar]
  10. Greenwood S. Hysterectomy and ovarian removal--a major health issue in the perimenopausal years. West J Med. 1988 Dec;149(6):771–772. [PMC free article] [PubMed] [Google Scholar]
  11. Griffin B., Farish E., Walsh D., Barnes J., Caslake M., Shepherd J., Hart D. Response of plasma low density lipoprotein subfractions to oestrogen replacement therapy following surgical menopause. Clin Endocrinol (Oxf) 1993 Oct;39(4):463–468. doi: 10.1111/j.1365-2265.1993.tb02394.x. [DOI] [PubMed] [Google Scholar]
  12. Irwin K. L., Wingo P. A., Lee N. C. Agreement of self-reported ovarian number following gynecologic surgery with medical record reports. J Clin Epidemiol. 1990;43(2):181–187. doi: 10.1016/0895-4356(90)90182-o. [DOI] [PubMed] [Google Scholar]
  13. Luoto R., Kaprio J., Reunanen A., Rutanen E. M. Cardiovascular morbidity in relation to ovarian function after hysterectomy. Obstet Gynecol. 1995 Apr;85(4):515–522. doi: 10.1016/0029-7844(94)00456-N. [DOI] [PubMed] [Google Scholar]
  14. Meade T. W., Berra A. Hormone replacement therapy and cardiovascular disease. Br Med Bull. 1992 Apr;48(2):276–308. doi: 10.1093/oxfordjournals.bmb.a072548. [DOI] [PubMed] [Google Scholar]
  15. Palmer J. R., Rosenberg L., Shapiro S. Reproductive factors and risk of myocardial infarction. Am J Epidemiol. 1992 Aug 15;136(4):408–416. doi: 10.1093/oxfordjournals.aje.a116513. [DOI] [PubMed] [Google Scholar]
  16. Pansini F., Bergamini C., Bettocchi S., Jr, Bassi P., Malfaccini M., Bagni B., Mollica G. Short-term effect of oophorectomy on lipoprotein metabolism. Gynecol Obstet Invest. 1984;18(3):134–139. doi: 10.1159/000299068. [DOI] [PubMed] [Google Scholar]
  17. Pansini F., Bonaccorsi G., Calisesi M., Campobasso C., Franze G. P., Gilli G., Locorotondo G., Mollica G. Influence of spontaneous and surgical menopause on atherogenic metabolic risk. Maturitas. 1993 Nov;17(3):181–190. doi: 10.1016/0378-5122(93)90045-j. [DOI] [PubMed] [Google Scholar]
  18. Pokras R., Hufnagel V. G. Hysterectomy in the United States, 1965-84. Am J Public Health. 1988 Jul;78(7):852–853. doi: 10.2105/ajph.78.7.852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Punnonen R., Rauramo L. Effect of bilateral oophorectomy and peroral estradiol valerate therapy on serum lipids. Int J Gynaecol Obstet. 1976;14(1):13–16. doi: 10.1002/j.1879-3479.1976.tb00560.x. [DOI] [PubMed] [Google Scholar]
  20. Punnonen R., Rauramo L. The effect of castration and estrogen therarapy on serum high-density lipoprotein cholesterol. Int J Gynaecol Obstet. 1980 Mar-Apr;17(5):434–436. doi: 10.1002/j.1879-3479.1980.tb00180.x. [DOI] [PubMed] [Google Scholar]
  21. RITTERBAND A. B., JAFFE I. A., DENSEN P. M., MAGAGNA J. F., REED E. GONADAL FUNCTION AND THE DEVELOPMENT OF CORONARY HEART DISEASE. Circulation. 1963 Feb;27:237–251. doi: 10.1161/01.cir.27.2.237. [DOI] [PubMed] [Google Scholar]
  22. Sightler S. E., Boike G. M., Estape R. E., Averette H. E. Ovarian cancer in women with prior hysterectomy: a 14-year experience at the University of Miami. Obstet Gynecol. 1991 Oct;78(4):681–684. [PubMed] [Google Scholar]
  23. Sonnendecker E. W., Polakow E. S. Effects of conjugated equine oestrogens with and without the addition of cyclical medrogestone on hot flushes, liver function, blood pressure and endocrinological indices. S Afr Med J. 1990 Mar 17;77(6):281–285. [PubMed] [Google Scholar]
  24. Wakatsuki A., Sagara Y. Lipoprotein metabolism in postmenopausal and oophorectomized women. Obstet Gynecol. 1995 Apr;85(4):523–528. doi: 10.1016/0029-7844(94)00452-J. [DOI] [PubMed] [Google Scholar]
  25. Watts N. B., Notelovitz M., Timmons M. C., Addison W. A., Wiita B., Downey L. J. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause. Obstet Gynecol. 1995 Apr;85(4):529–537. doi: 10.1016/0029-7844(94)00448-m. [DOI] [PubMed] [Google Scholar]
  26. Witteman J. C., Grobbee D. E., Kok F. J., Hofman A., Valkenburg H. A. Increased risk of atherosclerosis in women after the menopause. BMJ. 1989 Mar 11;298(6674):642–644. doi: 10.1136/bmj.298.6674.642. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES